What is the ROCE (Return on Capital Employed) of AxoGen this year?
The ROCE of AxoGen is -0.22 undefined this year.
AxoGen ROCE 2025
AxoGen ROCE
-0.22
Ticker
AXGN
ISIN
US05463X1063
WKN
A1JMHK
In 2025, AxoGen's return on capital employed (ROCE) was -0.22, a -23.71% increase from the -0.29 ROCE in the previous year.
AxoGen Aktienanalyse
What does AxoGen do?
AxoGen Inc is a US-American company based in Alachua, Florida. The company was founded in 2002 as a spin-off of the Grabowski Laboratory at the University of Florida. The goal of the company is to improve the regeneration of peripheral nerves through innovative products and solutions. AxoGen's business model is based on the development, production, and sale of biomaterial-based products for peripheral nerve regeneration. The company has three product categories: Avance nerve tissue, AxoGuard nerve wraps, and AxoTouch nerve testers. Avance nerve tissue is a proven technology for improving the regeneration of peripheral nerves. It consists of allogeneic nerve tissue from donors that has been prepared and sterilized for transplantation. Avance nerve tissue is used for surgical repair of nerve damage and has proven to be very effective in regenerating peripheral nerves. AxoGuard nerve wraps are silicone gels used for repairing nerve damage. They protect the delicate nerve fibers during the healing process and prevent scar formation. AxoGuard nerve wraps were designed to preserve the structure and function of nerves after surgical repair. AxoTouch nerve testers are devices used to measure nerve function. They are used to monitor and evaluate the integrity and function of peripheral nerves. This system is of great importance for assessing the surgical repair of nerve damage and monitoring the progress of healing. In recent years, AxoGen has experienced significant growth and has become a leading company in the field of peripheral nerve regeneration. The company has offices in the US and Europe and distributes its products worldwide. AxoGen is listed on the NASDAQ stock exchange and has a market capitalization of approximately $2.3 billion. AxoGen has made significant progress in recent years and has achieved several important milestones. In 2012, the company received approval from the US Food and Drug Administration (FDA) for the use of Avance nerve tissue for surgical repair of nerve damage. In 2014, AxoGen received CE marking for Avance nerve tissue and AxoGuard nerve wraps, thereby obtaining approval for the European market. AxoGen is continuously working on the development of new products and solutions to improve nerve regeneration. The company has a strong scientific foundation and is heavily involved in research. AxoGen also collaborates with leading scientists and clinics to improve its products and develop new applications. In summary, AxoGen is an innovative company specializing in the development and production of biomaterial-based products for peripheral nerve regeneration. The company has become a market leader in recent years and operates worldwide. AxoGen has brought proven technologies and products to the market that help improve nerve regeneration and enhance patients' quality of life. AxoGen ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling AxoGen's Return on Capital Employed (ROCE)
AxoGen's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing AxoGen's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
AxoGen's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in AxoGen’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about AxoGen stock
How has the ROCE (Return on Capital Employed) of AxoGen developed compared to the previous year?
The ROCE of AxoGen has increased by -23.71% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of AxoGen?
A high Return on Capital Employed (ROCE) indicates that AxoGen has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of AxoGen?
A low ROCE (Return on Capital Employed) can indicate that AxoGen has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from AxoGen impact the company?
An increase in the ROCE of AxoGen can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of AxoGen affect the company?
A decrease in ROCE of AxoGen can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of AxoGen?
Some factors that can affect AxoGen's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of AxoGen so important for investors?
The ROCE of AxoGen is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can AxoGen take to improve the ROCE?
To improve the ROCE, AxoGen can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does AxoGen pay?
Over the past 12 months, AxoGen paid a dividend of 1 USD . This corresponds to a dividend yield of about 5.41 %. For the coming 12 months, AxoGen is expected to pay a dividend of 0 USD.
What is the dividend yield of AxoGen?
The current dividend yield of AxoGen is 5.41 %.
When does AxoGen pay dividends?
AxoGen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of AxoGen?
AxoGen paid dividends every year for the past 0 years.
What is the dividend of AxoGen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is AxoGen located?
AxoGen is assigned to the 'Health' sector.
Wann musste ich die Aktien von AxoGen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of AxoGen from 2/12/2010 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 1/27/2010.
When did AxoGen pay the last dividend?
The last dividend was paid out on 2/12/2010.
What was the dividend of AxoGen in the year 2024?
In the year 2024, AxoGen distributed 0 USD as dividends.
In which currency does AxoGen pay out the dividend?
The dividends of AxoGen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von AxoGen
Our stock analysis for AxoGen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AxoGen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
